Ipamorelin is Certified Aminos' research listing for a selective GHS-R1a (ghrelin-receptor) agonist, studied for pulsatile GH release without meaningfully affecting cortisol or prolactin. Available in 5mg and 10mg for laboratory research use only.
HPLC certified
Independent analysis
Highest standard
Full traceability
Each order ships as an Ipamorelin research peptide in your choice of 5 or 10 mg vials, manufactured for laboratory use only.
| Product Name | Ipamorelin |
|---|---|
| Peptide Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| CAS Number | 170851-70-4 — compound-reference data, not yet matched to this product's own COA |
| Molecular Formula | C38H49N9O5 (free base) — compound-reference data |
| Molecular Weight | ≈711.9 g/mol (free base; varies by salt/hydrate form) — compound-reference data |
| Compound Form | Not confirmed whether this product is supplied as the free base or a salt form (e.g., acetate); salt form would change the molecular weight |
| Purity | Not independently verified — no batch-specific COA is currently published |
| Identity | Not independently confirmed by mass spectrometry or an equivalent method |
| Available Sizes | 5 mg / 10 mg |
| Intended Use | Laboratory research only (RUO) |
The CAS number, molecular formula, and molecular weight above describe the reference Ipamorelin compound as studied in the general chemical literature — they are not yet matched to this product's own certificate of analysis. When your order arrives, match the lot number on the vial to the lot number on the COA before beginning any work.
Tesamorelin and ipamorelin act on different GH pathways — here's what the human evidence on each shows, and why no study of the combination exists.
What is Ipamorelin? See what research shows about its mechanism, potential benefits, safety signals, and current FDA regulatory status for researchers.
HCG and LH bind the exact same receptor — yet research shows they send measurably different signals once they do. Here's what's actually established about HCG's structure, mechanism, and the FDA's position on HCG weight-loss claims.
